Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9461-9468

  Yi, Chae Ryun ^a   Rosenberg, Naomi ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; GAG PROTEIN; HYBRID PROTEIN; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN P120; VIRUS PROTEIN V;

ABELSON MURINE LEUKEMIA ONCOVIRUS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE SEQUENCE; GENETIC CODE; IMMUNOFLUORESCENCE; MYRISTYLATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS ONCOGENE; VIRUS TRANSFORMATION;

ABELSON MURINE LEUKEMIA VIRUS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL NUCLEUS; CELL TRANSFORMATION, VIRAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE PRODUCTS, GAG; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; ONCOGENE PROTEINS V-ABL; PHOSPHORYLATION; PROTEIN TRANSPORT; SEQUENCE DELETION;

ABELSON MURINE LEUKEMIA VIRUS;

EID: 34548169805     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00735-07     Document Type: Article

References (42)

1. Baker, S. J., S. C. Cosenza, and E. P. Reddy. 1998. The role of v-Fgr myristoylation and the Gag domain in membrane binding and cellular transformation. Virology 249:1-11.
2. Baughn, L. B., and N. Rosenberg. 2005. Disruption of the Shc/Grb2 complex during Abelson virus transformation affects proliferation, but not apoptosis. J. Virol. 79:2325-2334.
3. Daley, G. Q., R. A. Van Etten, P. K. Jackson, A. Bernards, and D. Baltimore. 1992. Nonmyristoylated Abl proteins transform a factor-dependent cell line. Mol. Cell. Biol. 12:1864-1871.
4. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106:87-102.
5. Engelman, A., and N. Rosenberg. 1990. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation. Mol. Cell. Biol. 10:4365-4369.
6. Engelman, A., and N. Rosenberg. 1990. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J. Virol. 64:4242-4251.
7. Franz, W. M., P. Berger, and J. Y. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
8. Gong, L., I. Unnikrishnan, A. Raghavan, K. Parmar, and N. Rosenberg. 2004. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells. J. Virol. 78:1636-1644.
9. Hantschel, O., S. Wiesner, T. Guttler, C. D. Mackereth, L. L. Rix, Z. Mikes, J. Dehne, D. Gorlich, M. Sattler, and G. Superti-Furga. 2005. Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl. Mol. Cell 19:461-473.
10. Kaplan, J. M., H. E. Varmus, and J. M. Bishop. 1990. The src protein contains multiple domains for specific attachment to membranes. Mol. Cell. Biol. 10:1000-1009.
11. Latt, S. A., S. P. Goff, C. J. Tabin, M. Paskind, J. Y. Wang, and D. Baltimore. 1983. Cloning and analysis of reverse transcript P160 genomes of Abelson murine leukemia virus. J. Virol. 45:1195-1199.
12. Mainville, C. A., K. Parmar, I. Unnikrishnan, L. Gong, G. D. Raffel, and N. Rosenberg. 2001. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain. J. Virol. 75:1816-1823.
13. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
14. Mayer, B. J., P. K. Jackson, R. A. Van Etten, and D. Baltimore. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12:609-618.
15. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
16. Parmar, K., R. C. Huebner, and N. Rosenberg. 1991. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction. J. Virol. 65:6478-6485.
17. Parmar, K., and N. Rosenberg. 1996. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation. J. Virol. 70:1009-1015.
18. Prywes, R., J. G. Foulkes, N. Rosenberg, and D. Baltimore. 1983. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569-579.
19. Prywes, R., J. Hoag, N. Rosenberg, and D. Baltimore. 1985. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus. J. Virol. 54:123-132.
20. Raffel, G. D., K. Parmar, and N. Rosenberg. 1996. In vivo association of v-Abl with She mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:4640-4645.
21. Reddy, E. P., M. J. Smith, and A. Srinivasan. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other one gene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. USA 80:3623-3627.
22. Rees-Jones, R. W., and S. P. Goff. 1988. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability. J. Virol. 62:978-986.
23. Rein, A., M. R. McClure, N. R. Rice, R. B. Luftig, and A. M. Schultz. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 83:7246-7250.
24. Rosenberg, N., and D. Baltimore. 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1453-1463.
25. Rosenberg, N., and O. N. Witte. 1980. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule. J. Virol. 33:340-348.
26. Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene. Adv. Virus Res. 35:39-81.
27. Scher, C. D., and R. Siegler. 1975. Direct transformation of 3T3 cells by Abelson murine leukaemia virus. Nature 253:729-731.
28. Schiff-Maker, L., M. C. Burns, J. B. Konopka, S. Clark, O. N. Witte, and N. Rosenberg. 1986. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules. J. Virol. 57:1182-1186.
29. Shore, S. K., R. V. Tantravahi, and E. P. Reddy. 2002. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene 21:8568-8576.
30. Soneoka, Y., S. M. Kingsman, and A. J. Kingsman. 1997. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. J. Virol. 71:5549-5559.
31. Spearman, P., J. J. Wang, N. Vander Heyden, and L. Ratner. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
32. Taagepera, S., D. McDonald, J. E. Loeb, L. L. Whitaker, A. K. McElroy, J. Y. J. Wang, and T. J. Hope. 1998. Nuclear-cytoplasmic shuttling of c-ABL tyrosine kinase. Proc. Natl. Acad. Sci. USA 95:7457-7462.
33. Van Etten, R. A. 2004. Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era. Leuk. Res. 28(Suppl. 1):S21-S28.
34. Van Etten, R. A., P. K. Jackson, D. Baltimore, M. C. Sanders, P. T. Matsudaira, and P. A. Janmey. 1994. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124:325-340.
35. Warren, D., D. S. Griffin, C. Mainville, and N. Rosenberg. 2003. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus. J. Virol. 77:4617-4625.
36. Warren, D., A. J. Heilpern, K. Berg, and N. Rosenberg. 2000. The carboxyl terminus of v-Abl protein can augment SH2 domain function. J. Virol. 74:4495-4504.
37. Wen, S. T., P. K. Jackson, and R. A. Van Etten. 1996. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15:1583-1595.
38. Wetzler, M., M. Talpaz, R. A. Van Etten, C. Hirsh-Ginsberg, M. Beran, and R. Kurzrock. 1993. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Investig. 92:1925-1939.
39. Yuan, B., X. Li, and S. P. Goff. 1999. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710.
40. Yueh, A., and S. P. Goff. 2003. Phosphorylated serine residues and an arginine-rich domain of the Moloney murine leukemia virus p12 protein are required for early events of viral infection. J. Virol 77:1820-1829.
41. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
42. Zou, X., and K. Calame. 1999. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J. Biol. Chem. 274:18141-18144.